Subscribe for the Newsletter

Mobile Navigation

Enabling Precision Medicine via Precision Diagnostics

FACible Biodiagnostics

FACible Biodiagnostics

Mar 19, 2022PAO-03-22-R250-13

Along the Road to 50 States, Steve Burden, founder and CEO of FACible Biodiagnostics, talks to Nigel about precision diagnostics and how precison medicine as a whole is the next big thing in pharma.

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.